Key facts
- Vitals In View (New York)’s last known valuation is $25.8M (Apr 2022).
- It has raised $9.6M; the latest was Later Stage VC in Apr 2025.
- Notable investors include Seedcamp, Hoxton Ventures, Digital Irish Venture Fund, Jamie Heslip, MASV (Ireland) — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Vitals In View (New York)
- ·The full record, as it builds
Funding rounds
No funding rounds for Vitals In View (New York) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Vitals In View (New York)
Developer of a fitness platform designed for users to lose fat and gain energy. The company's platform offers real-time guidance, a personalized weight loss program, by using smart wearables to track bio-data, enabling users with a unified, holistic picture of users fitness and hyper-personal recommendations on what to do next.
- Sector
- Consumer Products and Services (B2C)
- HQ
- New York, NY, United States
- Founded
- 2020
- Employees
- 36
- Website
- viv.co/
- Ownership
- Privately Held (backing)
Vitals In View (New York) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Vitals In View (New York) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Vitals In View (New York) in its N-PORT filings yet. We sweep new filings monthly.